MARISSEN, Janina, HAISS, Annette, MEYER, Claudius U., VAN ROSSUM, Thea, BÜNTE, Lisa Marie, FROMMHOLD, David, GILLE, Christian, GOEDICKE-FRITZ, Sybelle, GÖPEL, Wolfgang, HUDALLA, Hannes, PAGEL, Julia, PIRR, Sabine, SILLER, Bastian, VIEMANN, Dorothee, VENS, Maren, KÖNIG, Inke R., HERTING, Egbert, ZEMLIN, Michael, GEHRING, Stephan, BORK, Peer, HENNEKE, Philipp und HÄRTEL, Christoph, 2020. Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0–32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial : : the PRIMAL Clinical Study protocol. Freiburg: Universität.

Marißen, J., Haiß, A., Meyer, C.U., Van Rossum, T., Bünte, L.M., Frommhold, D., Gille, C., Goedicke-Fritz, S., Göpel, W., Hudalla, H., Pagel, J., Pirr, S., Siller, B., Viemann, D., Vens, M., König, I.R., Herting, E., Zemlin, M., Gehring, S., Bork, P., Henneke, P., Härtel, C., 2020. Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0–32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial : : the PRIMAL Clinical Study protocol. Universität, Freiburg. https://doi.org/10.1136/bmjopen-2019-032617

Marißen, J., Haiß, A., Meyer, C. U., Van Rossum, T., Bünte, L. M., Frommhold, D., Gille, C., Goedicke-Fritz, S., Göpel, W., Hudalla, H., Pagel, J., Pirr, S., Siller, B., Viemann, D., Vens, M., König, I. R., Herting, E., Zemlin, M., Gehring, S., Bork, P., Henneke, P., & Härtel, C. (ca. 2020). Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0–32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial : : the PRIMAL Clinical Study protocol [Cd]. Universität. https://doi.org/10.1136/bmjopen-2019-032617

Marißen J, Haiß A, Meyer CU, Van Rossum T, Bünte LM, Frommhold D, Gille C, Goedicke-Fritz S, Göpel W, Hudalla H, Pagel J, Pirr S, Siller B, Viemann D, Vens M, König IR, Herting E, Zemlin M, Gehring S, Bork P, Henneke P, Härtel C (2020) Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0–32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial : : the PRIMAL Clinical Study protocol. Universität, Freiburg

Marißen, Janina/ Haiß, Annette/ Meyer, Claudius U./ Van Rossum, Thea/ Bünte, Lisa Marie/ Frommhold, David/ Gille, Christian/ Goedicke-Fritz, Sybelle/ Göpel, Wolfgang/ Hudalla, Hannes/ Pagel, Julia/ Pirr, Sabine/ Siller, Bastian/ Viemann, Dorothee/ Vens, Maren/ König, Inke R./ Herting, Egbert/ Zemlin, Michael/ Gehring, Stephan/ Bork, Peer/ Henneke, Philipp/ Härtel, Christoph, Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0–32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial : : the PRIMAL Clinical Study protocol, Freiburg 2020.